Stephen Gordon

Stephen Gordon (finance chief) discloses dealings in TransMedics Group, Inc. to SEC (Form 4). The record holds 26 filings, for trades running from 1 June 2021 to 3 June 2024.

On the market, this insider has only sold: 2 sales, €414k in total. Outside the open market, there are 2 share grants and 21 option exercises. So far in 2024, the count stands at no purchases and 2 sales.

The record was last updated on 5 June 2024 with an option exercise (€73k) in TransMedics Group, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.